The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes.
OBJECTIVE
Genome-wide association studies have shown that variation in the FTO gene predisposes to obesity and related traits that are common features of polycystic ovary syndrome (PCOS). The aim of the present study was to assess the effect of FTO variation on obesity, insulin sensitivity, and metabolic and hormonal profiles in PCOS.


METHODS
We examined 136 PCOS women (mean body mass index [BMI]: 28.28+/-6.95kg/m(2), mean age: 25.36+/-5.48 years). Anthropometric measurement, euglycaemic-hyperinsulinaemic clamp and oral glucose tolerance tests and sex hormone assessments were performed. The study group was genotyped for the FTO rs9939609 polymorphism.


RESULTS
BMI (29.0+/-6.9kg/m(2) vs 26.1+/-6.8kg/m(2); P=0.023), body weight (80.1+/-20.7kg vs 72.6+/-20.2kg; P=0.048), fat mass (29.7+/-1 6.6kg vs 24.6+/-17.7kg; P=0.045) and waist circumference (89.8+/-16.7cm vs 83.2+/-17.1cm; P=0.028) were higher in carriers of at least one copy of the A allele. Differences in these parameters were more significant when comparing AA and TT homozygotes. Women with the AA genotype also had decreased insulin sensitivity (P=0.025) and follicle-stimulating hormone (P=0.036). In logistic-regression analyses, the association of the FTO gene polymorphism with insulin sensitivity was no longer significant when BMI was included in the model.


CONCLUSIONS
Variation in the FTO gene modifies weight, adiposity and other measures of obesity and insulin sensitivity in PCOS. The examined FTO gene variant appears to have a greater impact on obesity and related traits in PCOS than in other phenotypes. The effect on insulin sensitivity appears to be secondary to its influence on obesity and body fat.
Kowalska
I
I
Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Białystok, Poland. irinak@poczta.onet.pl
Malecki
M T
MT
Straczkowski
M
M
Skupien
J
J
Karczewska-Kupczewska
M
M
Nikolajuk
A
A
Szopa
M
M
Adamska
A
A
Wawrusiewicz-Kurylonek
N
N
Wołczynski
S
S
Sieradzki
J
J
Gorska
M
M
D050154:Adiposity / Q000235:genetics*; D000328:Adult; D000071516:Alpha-Ketoglutarate-Dependent Dioxygenase FTO; D001823:Body Composition / Q000235:genetics*; D015992:Body Mass Index; D005260:Female; D005787:Gene Frequency; D056726:Genetic Association Studies; D015309:Glucose Clamp Technique; D005951:Glucose Tolerance Test; D012739:Gonadal Steroid Hormones / Q000097:blood; D006801:Humans; D007333:Insulin Resistance / Q000235:genetics*; D009765:Obesity / Q000150:complications*; D011044:Poland; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000235:genetics* / Q000503:physiopathology; D011110:Polymorphism, Genetic; D011506:Proteins / Q000235:genetics* / Q000502:physiology; D055105:Waist Circumference; D055815:Young Adult
D012739:Gonadal Steroid Hormones; D011506:Proteins; D000071516:Alpha-Ketoglutarate-Dependent Dioxygenase FTO; C526492:FTO protein, human